A dream of perfection and control?

a mind control system that can conduct financial transactions without a passbook or deposit / withdrawal card

“In 2014, I attended TED’s main Vancouver conference and watched the opening talk, from the MIT Media Lab founder Nicholas Negroponte. In his closing words, he claimed that in 30 years, “we are going to ingest information. You’re going to swallow a pill and know English. You’re going to swallow a pill and know Shakespeare. And the way to do it is through the bloodstream. So once it’s in your bloodstream, it basically goes through it and gets into the brain, and when it knows that it’s in the brain, in the different pieces, it deposits it in the right places.”

https://www.theatlantic.com/science/archive/2019/07/ten-years-human-brain-project-simulation-markram-ted-talk/594493/

I looked around for some more stories on graphene from various publications:

https://www.cryptoninjas.net/2018/07/26/graphene-timeline-a-strange-history-and-recent-rise/

Graphene. If you’re familiar with it, you’ve probably heard of its futuristic characteristics, the research that’s being conducted around it, and the companies who are spending undisclosed amounts of intellectual and financial resources to study its advantages. The interest in graphene has grown exponentially, but it didn’t happen overnight. It’s been a long time coming for graphene, from the 1500’s to the present day.

The 1560s: Simonio and Lyndiana Bernacotti developed the First Pencil

An Italian couple by the name of Simonio and Lyndiana Bernacotti invented the first carpentry pencil. The pencil was made using a hollow stick and a graphite strip. Fun fact, today we still refer to the black core of a pencil as lead, but it’s actually made from graphite.

1924: John Desmond Bernal – Layered Structure of Graphite

John Desmond Bernal was an Irish scientist who researched at the Davy Faraday Laboratory in London. While in London, he determined the structure of Graphite; this catalyzed theoretical research around the compounds atomic structure.

1947: Theoretical Studies – A Single Graphite Sheet

In the 1940’s, scientists around the world began to explore the idea of a single graphite sheet. However, most believed that creating the physical sheet was impossible.

2004: The Discovery of Graphene

In 2004, University of Manchester researchers Andre Geim and Konstantin Novoselov used scotch tape to create a single layer of Graphite. The discovery proved that graphene was a real possibility.

2008: Graphene Ink

By using exfoliation methods, scientists were able to produce graphene ink, a carbon nanomaterial that opened an array of possibilities for printed and flexible electronics. Thin-film transistors (TFTs) and electrochemical sensors were two technologies enhanced by this finding.

2009: Transparent Electrodes

For the first time, graphene was used as transparent electrodes. Electrodes are conductors which enable the movement of electricity. This new finding expanded the potential of graphene, allowing it to be used for large-scale displays and solar cells.

2010: Nobel Prize

In 2010, Manchester University researchers Andre Geim and Konstantin Novoselov were awarded the Nobel Prize in physics for their 2004 finding.

2012: Photodetectors and Electronics

In 2012, the first graphene-based photodetectors were made, revealing graphene’s extraordinary ability to convert light photons into a current. That same year, Inkjet-printed graphene electronics were discovered.

2013: Graphene Flagship Launched

In 2013 the EU launched the Flagship, EU’s most significant research initiative ever. With a budget of €1 billion, it represented a new type of research initiative on an unprecedented scale. The goal of the Flagship is to commercialize graphene technologies within ten years of the initiative’s creation.

2014: Graphene Improves Battery Capacity

Similar to regular batteries, graphene batteries have two electrodes and an electrolyte solution to facilitate ion transfer; however, the difference between the two is in the composition of electrons. Researchers found that graphene batteries improved electrodes and boosted battery performance.

2015: Graphene-based Magnetic Field Sensor

Researchers find that graphene can be used to improve the detection and measuring of magnetic fields, enabling further expansion into the field of electronics and electromagnetism.

2016: Dynamic Applications – Phones, Cars, Planes, and Data

Graphene is officially used for mobile phones including screens, batteries, and cooling systems. Graphene is also being used in cars, aircraft, and data transmission.

2017: Solar Energy

Graphene enters the renewable energy space in the form of large-scale solar cells used in interface engineering and solar production.

2018: Graphene meets Blockchain

GraphenTech comes to market as the world’s first blockchain company based on graphene material. Through their 77G coin, GraphenTech is financing the development of their proprietary technologies which will enable the industrial production of graphene.

World Economic Form states: Ten years ago this all sounded like science fiction. But governments have since invested nearly US$ 70 billion in nanotechnology research, eager to be at the forefront of this revolution. This will be like the shift from horses to the internal combustion engine, or from vacuum tubes to silicon chips; a transformation enabling new industries to flourish.

As you may know European Union and the United States spent billions on Graphene FlagShip, on Human Brain Project and U.S. BRAIN Initiative

In 2014, almost 800 neuroscientists wrote an open letter to the European Commission saying that “the HBP is not a well-conceived or implemented project and that it is ill suited to be the centerpiece of European neuroscience.” A year later, a mediation committee agreed with the critics, asking the HBP to refocus its efforts “on a smaller number of properly prioritized activities” and to retool its unorthodox governance structure.

https://www.theatlantic.com/science/archive/2019/07/ten-years-human-brain-project-simulation-markram-ted-talk/594493/

Open message to the European Commission concerning the Human Brain Project July 7, 2014 We the undersigned members of the European neuroscience community are writing to express our concern with the course of the Human Brain Project (HBP). The HBP, and its cousin the U.S. BRAIN Initiative, have the noble goal of making major advances in our understanding of both normal and pathological brain function. Given the potentially enormous benefits to society that would be gained from achieving this goal, it deserves a significant collective investment of our societies’ resources. However, the HBP has been controversial and divisive within the European neuroscience community from the beginning. Many laboratories refused to join the project when it was first submitted because of its focus on an overly narrow approach, leading to a significant risk that it would fail to meet its goals. Further attrition of members during the ramp­up phase added to this narrowing. In June, a Framework Proposal Agreement (FPA) for the second round of funding for the HBP was submitted. This, unfortunately, reflected an even further narrowing of goals and funding allocation, including the removal of an entire neuroscience subproject and the consequent deletion of 18 additional laboratories, as well as further withdrawals and the resignation of one member of the internal scientific advisory board. A formal review of the HBP is now scheduled to evaluate the success of the project’s ramp­up phase and the plan for the next phase. At stake is funding on the order of 50M€ per year European Commision for the “core project” and 50M€ in “partnering projects” provided largely by the European member states’ funding bodies. In this context, we wish to express the view that the HBP is not on course and that the European Commission must take a very careful look at both the science and the management of the HBP before it is renewed. We strongly question whether the goals and implementation of the HBP are adequate to form the nucleus of the collaborative effort in Europe that will further our understanding of the brain. It is stated that the review must address the excellence, impact as well as the quality and efficiency of implementation. We believe that a review will show that there are substantial failures to meet these criteria, especially concerning the quality of the governance demonstrated and the lack of flexibility and openness of the consortium. In order to carry out the upcoming review in the most transparent and accountable manner possible, we hold that it should meet the following criteria: ● The panel should be composed of highly regarded members of the scientific community whose views reflect the diversity of approaches within neuroscience. ● The review process should be transparent: review panel members identities should be disclosed and the goals, procedures and output of the review process should be public. ● The panel should be independent: the members of the panel should not be involved in the development of, advocacy for, or governance of the HBP; they should provide a signed disclosure of any significant funding or scientific relationships to the HBP. ● The EC must by regulation evaluate if the HBP is meeting the core criteria of the FET Flagship Project, including scientific excellence, impact and quality of implementation. We call attention to concerns raised by the sparse community support and systematic loss of HBP partners that appear highly relevant to the FET criteria of: ○ Extent to which the consortium enables fostering complementarities, exploiting synergies, and enhancing the overall outcome of regional, national, European and international research programmes ○ Quality of the proposed governance and management structure ○ Openness and flexibility of the consortium ● Based on this review, the panel should make binding recommendations concerning the continuation of the HBP as a whole as well as continuation of individual subprojects, including the allocation of resources across subprojects and the possible creation of new subprojects. ● The panel should be tasked and empowered to create a transparent process for the formulation of the calls for partnering projects and the review of applications for those calls, such that these reflect community input, are coordinated with the core but are independent of the core administration. ● One or more members of the panel should continue to serve as the core of an external steering committee for the period of the funding under review. These continuing members would need to be fully independent of the project (i.e. receiving no funding). In the case that the review is not able to secure these objectives, we call for the European Commission and Member States to reallocate the funding currently allocated to the HBP core and partnering projects to broad neuroscience­directed funding to meet the original goals of the HBP—understanding brain function and its effect on society. We strongly support the mechanism of individual investigator­driven grants as a means to provide a much needed investment in European neuroscience research. The European Research Council would provide a well­proven mechanism for allocating such funds. In the event that the European Commission is unable to adopt these recommendations, we, the undersigned, pledge not to apply for HBP partnering projects and will urge our colleagues to join us in this commitment.

Moshe Abeles. Bar­Ilan University. Israel. Ad Aertsen. University of Freiburg. Germany. Silvia Arber. FMI. Switzerland. Philippe Ascher. University of Paris. France. Francesco Battaglia. Radboud Universiteit. Netherlands. Heinz Beck. University of Bonn. Germany. James Bednar. University of Edinburgh. UK. Tim Behrens. Oxford University. UK. Suliann Ben Hamed. ISC Lyon. France. Benedikt Berninger. University Medical Center Mainz. Germany. Hugues Berry. INRIA. France. Matthias Bethge. University of Tuebingen. Germany. Timothy Bliss. MRC. UK. Vincent Bonin. NERF. Belgium. Jan Born. University of Tübingen. Germany. Axel Borst. MPI. Germany. Gerard Borst. Erasmus MC Rotterdam. Netherlands. Michael Brecht. BCCN.Germany. Nils Brose. MPI. Germany. Jo Bury. VIB. Belgium. Matteo Carandini. UCL. UK. Alan Carleton. University of Geneva. Switzerland. Pico Caroni. FMI. Switzerland. Frederic Chavane. CNRS Marseille. France. Leonardo Chelazzi. University of Verona. Italy. Eugenia Chiappe. Champalimaud Centre for the Unknown. Portugal. Albert Compte. IDIBAPS Barcelona. Spain. Rui Costa. Champalimaud Centre for the Unknown. Portugal. Peter Dayan. University College of London. UK. Alexandre Dayer. University of Geneva. Switzerland. Gonzalo de Polavieja. Champalimaud Centre for the Unknown. Portugal. Chris de Zeeuw. Erasmus MC, Rotterdam. Netherlands. Sophie Deneve. ENS. France. Winfried Denk. MPIMR Heidelberg. Germany. Mathew Diamond. SISSA. Italy. David DiGregorio. Institut Pasteur. France. Ray Dolan. UCL. UK. Rodney Douglas. ETH. Switzerland. Andreas Draguhn. University of Heidelberg. Germany. Jean Rene Duhamel. ISC Lyon. France Thomas Euler. University of Tubingen. Germany. Karl Farrow. NERF. Belgium. Julia Fischer. Leibniz Institut fur Primatentforschung. Germany. Joszef Fiser. CEU. Hungary. Tamar Flash. Weizmann Institute. Israel. Eckhard Friauf. University of Kaiserslautern. Germany. Rainer Friedrich. FMI. Switzerland. Pascal Fries. ESI and MPI. Germany. Chris Frith. UCL. London. Vittorio Gallese. University of Parma. Italy. Theo Geisel. MPI. Germany. Martin Giese. University of Tübingen. Germany. David Golomb, Ben­Gurion University, Israel. Lyle Graham. CNRS, U Paris Descartes. France. Boris Gutkin. ENS. France. Helmut Haas. University of Dusseldorf. Germany. Sebastian Haesler. NERF. Belgium. Richard Hahnloser. ETH. Switzerland. David Hansel. University of Paris. France. Riitta Hari. Aalto University. Finland. Ken Harris. UCL. UK. Michael Hausser. UCL. UK. Fritjof Helmchen. University of Zurich. Switzerland. Moritz Helmstaedter. MPI. Germany. Matthias Hennig. University of Edinburgh. UK. Sonja Hofer. University of Basel. Switzerland. Klaus­Peter Hoffmann. Ruhr University Bochum. Germany. Daniel Huber. University of Geneva. Switzerland. Denis Jabaudon. University of Geneva. Switzerland. Reinhard Jahn. MPIMR. Germany. Peter Janssen. KU Leuven. Belgium. Sebastian Jessberger. University of Zurich. Switzerland. Adam Kampff. Champalimaud Centre for the Unknown. Portugal. Jason Kerr. Caesar. Germany. Jozsef Kiss. University of Geneva. Switzerland. Fabian Kloosterman. NERF. Belgium. Etienne Koechlin. ENS. France. Arvind Kumar. University of Freiburg. Germany. Peter Latham. UCL. UK. Gilles Laurent. MPI Frankfurt. Germany. Mate Lengyel. Cambridge University. UK. Juan Lerma Gomez. Instituto de Neurociencias Alicante. Spain. Susana Lima. Champalimaud Centre for the Unknown. Portugal. Nikos Logothetis. MPI Tübingen. Germany. Heiko Luhmann. University Medical Center Mainz. Germany. Giuseppe Luppino. University of Parma. Italy. Andreas Luthi. FMI. Switzerland. Christian Machens. Champalimaud Centre for the Unknown. Portugal. Zachary Mainen. Champalimaud Centre for the Unknown. Portugal. Rafael Malach. Weizmann Institute. Israel. Miguel Maravall. Instituto de Neurociencias Alicante. Spain. Troy Margrie. NIMR. UK. Kevan Martin. ETH. Switzerland. Guillaume Masson. CNRS Marseille. France. Gero Miesenboeck. Oxford. UK. Marta Moita. Champalimaud Centre for the Unknown. Portugal. Edvard Moser. Kavli Institute. Norway. May­Britt Moser. Kavli Institute. Norway. Tom Mrsic­Flogel. University of Basel. Switzerland. Andreas Neef. MPIMR. Germany. Israel Nelken. Hebrew University. Israel. Stephan Neuhauss. University of Zurich. Switzerland. Andreas Nieder. University of Tübingen. Germany. Hendrikje Nienborg. University of Tübingen. Germany. Zoltan Nusser. Institute of Experimental Medicine. Hungary. Guy Orban. University of Parma. Italy. Christophe Pallier, CNRS­INSERM, Paris­Saclay, France Stefano Panzeri. Italian Institute of Technology. Italy. Rony Paz. Weizmann Institute. Israel. Barak Pearlmutter. NUI Maynooth. Ireland. Mathias Pessiglione. ICM. France. Chris Petkov. Newcastle University. UK. Leopoldo Petreanu. Champalimaud Centre for the Unknown. Portugal. Alexandre Pouget. University of Geneva. Switzerland. Martin Raff. UCL. UK. Alfonso Renart. Champalimaud Centre for the Unknown. Portugal. Giacomo Rizzolatti. Università di Parma. Italy. David Robbe. INMED. France. Botond Roska. FMI. Switzerland. Stefan Rotter. University of Freiburg. Germany. Nava Rubin. ICREA and DTIC, Universitat Pompeu Fabra. Spain. Simon Rumpel. IMP. Austria. Matthew Rushworth. University of Oxford. UK. Stefan Schaal. MPI. Germany. Andreas Schaefer. NIMR UCL. UK Peter Scheiffele. University of Basel. Switzerland. Elad Schneidman. Weizmann Institute. Israel. Jan Schnupp. University of Oxford. UK. Bernhard Scholkopf. MPI Tübingen. Germany. Erin Schuman. MPI Frankfurt. Germany. Martin Schwab. University of Zurich. Switzerland. Cornelius Schwarz. University of Tuebingen. Germany. Sophie Schwarz.University of Geneva.Switzerland. Peggy Series. University of Edinburgh. UK. Noam Shemesh. Champalimaud Centre for the Unknown. Portugal. Oren Shriki. Ben Gurion University. Israel. Angus Silver. UCL. UK. Angela Sirigu. ISC Lyon. France. Haim Sompolinsky. Hebrew University. Israel. Walter Stuhmer. MPI. Germany. German Sumbre. ENS, France. Alexandre Thiele. Newcastle University. UK. Peter Thier. University of Tübingen. Germany. Simon Thorpe. CNRS Toulouse. France. Alessandro Treves. SISSA. Italy. Nachum Ulanovsky. Weizmann Institute. Israel. Wim Vanduffel. KU Leuven. Belgium. Rufin Vogels. KU Leuven. Belgium. Patrik Vuilleumier. University of Geneva. Switzerland. Felix Wichmann. University of Tuebingen. Germany. David Willshaw. University of Edinburgh.UK. Fred Wolf. MPI Göttingen. Germany. Daniel Wolpert. Cambridge University. UK. Emre Yaksi. NERF. Belgium

Perhaps, what these scientists knew or didn't know, the founders were just looking for specific ways to use this knowledge and the combined technology?

Has it been used in these injections? Those behind their push should answer.

GRAPHENE – AN OPEN SOURCE BLOCKCHAIN

By now, you have likely heard words like "bitcoin" and "blockchain," perhaps even "Ethereum," and wondered what they all mean.

Do they refer to something useful, and if so, how would you go about using it?

This article is intended to put meaning behind these words and others, by highlighting one instance of the technology behind the concepts.

Blockchain, like many other technologies supported and used by OCI, is middleware. It is not an end in itself; rather it is the means to an end. 

Blockchains are useful in the way databases are, storing data and allowing its manipulation, but with a twist. Data is stored in a blockchain as an immutable record of transactions. Integrity of the chain is maintained through the use of an algorithm, which verifiably links each new block to the history of blocks that precede it back to the origin of the chain.

Graphene, an Open Source, mostly C++, blockchain implementation was originally developed as the foundation of Bitshares, a cryptocurrency exchange marketplace.

The Graphene source is available in numerous variations, as it has been forked and adapted many times. The original release is managed by an organization known as Cryptonomex.

Graphene is interesting because it is Open Source, but also because it was developed in a modular fashion, making it adaptable to many different uses.

In addition to Bitshares, Graphene serves as the blockchain foundation for Steemit.com, a news aggregation site similar in concept to reddit.com and PeerPlays.com, a gaming site.

FollowMyVote.com is another example of a service built on the Graphene blockchain. FollowMyVote uses Graphene to facilitate secure, yet private, internet-based municipal voting.

There are many other users of Graphene beyond this sample list.

https://patents.google.com/patent/KR20170090373A/en

Mind control system for human interfaces

Abstract

The present invention relates to a mind control system for controlling a human using a brain wave map and a genetic map. According to the present invention, the mind control system comprises: a nano-electronic chip (NEC) inserted or attached to a human body to transmit and receive a wireless signal; at least one nano-biosensor (NBS) for transmitting an electrical signal generated from the NEC to nerve cells and human cells, and embedded or connected to the NEC for sensing biometric information; and a main super computer (MSC) for transmitting the wireless signal to the NEC to arbitrarily control the nerve cells and genes of the human body, and also used in wired Internet. According to the present invention, a cranial nerve can be controlled such that the physically handicapped can perform an intended action.

Also, the mind control system of the present invention is expected to be used for a trading means and a financial transaction including confirmation of personal identification.

In recognition of the individual's biometric information, the nano-electronic chip communicates bi-directionally with a personal smartphone using a cellular phone Wi-Fi, transmits biometric information of a human body to a smartphone, The third hospital computer designated by the individual can recognize the biometric information of the individual stored in the smartphone and stored in the smartphone, and simultaneously makes a video call.

For marketing means and financial transactions, the nanoelectronic chip may be used for three-way or more Wi-Fi communication with a main supercomputer (MSC) or a regional network control computer (CC) and a third large merchant & And the nano electronic chip can be used as a means of sale for settlement calculation of purchases made by a computer for a merchant using a Wi-Fi. In addition, the nano electronic chip can be used for a bank window It is a technology that can do financial transactions without a bankbook or withdrawal card at the time of transaction.

The present invention relates to a technique of stimulating brain cells by electroencephalography (EEG), which changes the magnetic field to change the image by applying a magnetic field to stimulate nerve cells by injecting current into the brain tissue and changing the ultrasound pattern Storing a program of the ultrasound device in a nano electronic chip,

Genetic map of the genetic map of the genetic disease among mutated 120-136 genome code (DNA Code), which is a unique combination of 3 million chromosomes in human beings. step,

(B) Charging by biocharging by the human body's electric force or by temperature change of the human body's skin and air, or by electromagnetic waves emitted from a GPS (Global Positioning System) or a control computer (CC) of a Wi- Embedding a rechargeable battery capable of wireless charging into an electronic chip,

The nanoelectronic chip circuit is extremely small (0.4mm / sphere size, future, 0.052mm, powder type) by nano-integration technology (NT) in which information function of EEG map and genetic map is stored. Modifying the skin into a very small size by attaching (tattooing, marking) to the skin,

It has human intelligence level software, analyzes medical clinical information from vast amount of patient data, predicts future and prescribes it, analyzes EEG map and gene map transmitted from nano electronic chip, Storing in a main supercomputer (MSC) a program for arbitrarily adjusting a nerve cell and a gene of a human body by retransmitting to a chip,

Bi-directional communication with a personal smartphone using Wi-Fi is possible. Personal information can be recognized by transmitting biometric information of a human body to a smart phone. At the same time, Storing the program in the nano electronic chip so as to recognize the biometric information of the person stored in the phone,

A program that allows you to conduct financial transactions without bankbook or deposit card at the bank window (including entry and exit), including the means of sale and settlement of accounts purchased by the merchant computer using Wi-Fi (Wi-Fi) And storing it in a nano electronic chip.

By analyzing the electrical signals generated by the brain using EEG maps and adjusting the cranial nerves using magnetic field technology or ultrasonic devices, the blind can see things, and the deaf It will be possible.

In addition, 120-136 genetic codes (DNA Code), which is a unique combination of 3 million bases in human beings, can be used for early detection of human genetic diseases and gene regulation, resulting in excellent brain, perfect flesh, It is to make post-human who is strong in disease. In other words, genetic diseases, mutated cell phenomenon can be detected, and the disease can be treated by adjusting the gene causing the disease.

In addition, biometrics information of the human body can be transmitted to a smart phone so that individuals can recognize the information, and it is expected to be used for trading means including personal identification, and financial transactions.

FIG. 1 is a block diagram of a human interface mind control system FLOW SHEET
FIG. 2 is a block diagram of the LOGIC DIAGRAM
FIG. 3 is a block diagram of the nano electronic chip structure of the human interface mind control system of the present invention.

The present invention will now be described in detail with reference to the accompanying drawings.

1 shows a conceptual diagram (FLOW SHEET) of the human interface mind control system of the present invention,

(CC) 31, a main supercomputer (MSC) 30 and a GPS (Global Positioning System) or GPS (Wi-Fi) satellite (39). It stores and analyzes wirelessly transmitted information from a nano electronic chip, sends a radio signal to a nano electronic chip, arbitrarily adjusts the nerve cells and genes of the human body, Cure.

The main supercomputer can share the medical treatment information, which is the result of the biometric information analysis, with the Wi-Fi communication system and the medical clinical information held by each national intelligence agency, Furthermore, we can provide database information to our global customers to provide health information that can benefit everyone for medical technology that predicts the future.

In addition, the nano-electronic chip performs bidirectional communication with a personal smartphone 34 using Wi-Fi, and displays biometric information of a human body temperature, heartbeat count, blood glucose level, blood pressure, blood concentration, The third hospital computer 33 designated by the individual can transmit the biometric information of the individual stored in the smartphone 34 via the Internet 37 to the smartphone 34 And can make video calls at the same time.

In addition, an individual adjusts the smartphone 34 to transmit the electric power generated from the nano generator (NG) 54 due to the piezoelectric effect of the human muscle movement incorporated in the nano electronic chip to the organs of the human body, And a nano-bio robot (NBR) that moves the blood vessel to treat a disease of a human body using the electric power as a power source.

In another function, the nano electronic chip includes a main supercomputer (MSC) 30 or a control computer (CC) 31, a third large merchant computer 35 and a financial institution computer 36, Wi-Fi communication,

The Nano electronic chip can be used for trading means for settlement calculation of purchased goods by the merchant computer 35 using Wi-Fi. In addition, the nano electronic chip can be used for banking (including entry / exit) It is a mind control system that can conduct financial transactions without a passbook or deposit / withdrawal card.

2 is a block diagram of a logic diagram for maximizing the functions of the human interface mind control system of the present invention.

A control computer (CC) (31) and a main supercomputer (MSC) (30) send radio signals to nanoelectronic chips to arbitrarily adjust the nerve cells and genes of the human body to treat various diseases including physically handicapped persons and genetic diseases, The nano electronic chip transmits the biometric information to the smartphone 34 so that the individual can recognize the information. The nano electronic chip sends the electric power generated from the nano generator (NG) 54 or the nano charger battery 53 to each organ of the human body A nano bio robot (NBR) capable of treating a disease by electric force stimulation and moving to a blood vessel for treating a disease of a human body using the electric power as a power source, In addition, the nano electronic chip is characterized by the ability to conduct financial transactions without bankbook or deposit / withdrawal card at the bank window (including entry / exit), including personal identification The mind control system.

Looking at the configuration and operation,

From the nanoelectronic chip into which the identification code (ID, RFID) is input, the human brain information from the human brain map and genetic map is used by the electronic waves such as microwaves transmitted from GPS or Wi-Fi satellites And wirelessly transmitted to a control computer (CC) 31 and a main supercomputer (MSC) 30 of the local network. After storing and analyzing wirelessly transmitted information from the nano electronic chip, the wireless signal is transmitted to the nano electronic chip The nanoelectronic chip, which receives the signal, executes the stored program and executes the mind control to arbitrarily adjust the human body's specific nerve cell and gene through the nano-biosensor (NBS).

The control computer 31 of the local network can execute the mind control alone with the nano-chip chip separately from the main super computer.

At this time, it is possible to use a blue beam instead of an electromagnetic wave transmitted from a GPS (Global Positioning System) or a Wi-Fi satellite.

In addition, the nano-electronic chip can utilize a cellular phone Wi-Fi and perform bi-directional communication with the personal smartphone 34. The nano-electronic chip can receive the temperature, heartbeat count, The blood pressure, the blood concentration, and the cell development dimension to the smartphone 34 so that the individual can recognize the information by the smartphone 34. At the same time, the third hospital computer 33, which is designated by the individual, The biometrics information of the individual stored in the smart phone 34 via the Internet 37 can be recognized and a video call can be made between the individual and the hospital.

At this time, the bio-information recognized by the nano-biosensor 55 is transmitted to the control computer 31 and the main super computer 30 of the local network by using the electromagnetic waves sent from a GPS (Global Positioning System) or a Wi-Fi ) To be stored.

The control computer 31 and the main supercomputer 30, which have received the biometric information, store and analyze the information and transmit the cellular phenomenon information generated by the disease to a GPS (Global Positioning System) or a Wi-Fi satellite To the smartphone 34 held by the individual so that the individual recognizes his / her own biometric information and allows the individual to directly treat the site where the disease occurs.

That is, the electric power generated from the nano generator (NG) 54 or the charger battery 53 built in the nano electronic chip due to the piezoelectric effect of the human muscle movement by the individual using the smartphone 34 is converted into a specific organ Muscle, joints, large intestine, small intestine, stomach, etc.) to treat the disease by electric stimulation,

In addition, a nano-bio robot (NBR) which moves the blood to the blood vessel using the electric power as a power source can be used to pulverize and neutralize cancer cells, collins, foreign substances,

In another function, the nano electronic chip is connected to a main supercomputer (MSC) 30 or a regional network control computer (CC) 31, a third large merchant computer 35 and a financial institution computer 36, Direction Wi-Fi communication,

The Nano electronic chip can be used for trading means for settlement calculation of purchased goods by the merchant computer 35 using Wi-Fi. In addition, the nano electronic chip can be used for banking (including entry / exit) Financial transactions can be made without a bankbook or withdrawal card. This also stores real-time information on the trading and financial transactions in the main supercomputer (MSC) 30 and the control computer (CC) 31 via a GPS (Global Positioning System) or a Wi-Fi do.

3 shows a nano electronic chip of the human interface mind control system of the present invention,

A VeriChip (microchip) capable of communicating with an external reader (ID) and information with an ID code was developed 10 years ago, but the recognition distance is about 5cm (low frequency: 1.8m, It is used only in some fields of everyday life such as access identification card, bank card, animal identification card, etc. However, there is a limit to the utilization of the third field.

However, with the development of nano-integration technology (NT) in the semiconductor field, Yosai is being developed into ultra-small size that can store, analyze and execute vast amount of data and programs.

The nano electronic chip of the human interface mind control system of the present invention is inserted into or attached to a human body to generate an electroencephalogram (BM), a gene map (GM) and an identification code (ID, RFID And is composed of a transceiver 52, a nano generator 54, a rechargeable battery 53, and a nano-biosensor 55, and a nano-bio robot is additionally provided.

In detail,

The individual gene map is programmed into the nano electronic chip (NCC) to which the identification code (ID, RFID) 50 is inputted, the control computer (CC) 31 and the main super computer (MSC) 30 of the local network (Wi-Fi) communication system, respectively.

When there is a genetic disease of a person and a mutated gene, biometric information is detected by the nano biosensor (NBS) 55 of the nano electronic chip (NCC) from the control computer (CC) 31 of the local network and the main super computer (MSC) 30 analyzes the information of the gene by the inputted gene adjustment program, the main supercomputer (MSC) 30 transmits the analysis information to the nano electronic chip (NCC) and the control of the local network The nano electronic chip (NCC) receives the electric signal for executing a command for changing the combination of specific bases to the nano biosensor (55) It is possible to cure the individual's genetic disease, the physically handicapped, and the various disease-bearing illnesses.

(EEG map and genetic map programs are not shown in the drawing)

In addition, it transmits electric signals generated from nanoelectronic chips to nerve cells and human cells, and it is able to transmit cellular signals such as cellular phenomena (NBS) 55 built in or connected to a nanoelectronic chip for sensing biometric information of dimensions,

In addition, nano electronic chips are inserted into the skin of hands, arms, shoulders, foreheads, heads and necks of the human body to facilitate transmission and reception, and are attached in the form of marks and tattoos on the skin. The nano generator (NG) 54 is built by the piezoelectric effect of the human muscle. The nano generator 54 is charged by the electric power generated from the nano generator or by the temperature change of the human skin and the air, ) Or a rechargeable battery 53 capable of wirelessly charging by an electromagnetic wave transmitted from a control computer (CC) of a Wi-Fi satellite or a local network,

Separately, the nano-electronic chip performs bidirectional communication with a personal smartphone 34 using a cellular phone Wi-Fi, transmits biometric information of a human body to the smartphone 34, The third hospital computer 33 designated by the individual can recognize the biometric information of the individual stored in the smartphone 34 via the Internet 37 and can make a video call.

Incidentally, an individual adjusts the smartphone 34 to send the electric power of the nano generator 54 built in the nano electronic chip or the electric power of the charger battery 53 to each organ of the human body to treat the disease by electric stimulation And a nano-bio robot (NR) that moves to a blood vessel for the purpose of treating a disease of a human body using the electric force as a power source.

As described above, the nanoelectronic chip is a crystal of biotechnology, biochemistry, medicine, electronic engineering, control engineering, communication engineering, neural network communication, gene engineering, and material engineering.

It will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from the spirit and scope of the present invention as defined by the following claims. .

Although the mind control system of the personal interface of the present invention has not yet been utilized in the field of life, since the Wi-Fi satellite technology will be integrated into the wireless Internet anywhere on the earth, Especially, through the extensive medical information, it is possible to give the owner of the nano electronic chip a treatment for disease and a healthy life for the physically handicapped person. Also, it can be used for identity theft for theft or theft of personal identification card. It is expected that it will be used for our everyday life in the future because it can be conveniently used as a means of trading in.

Is this why so many are injured and killed by the toxicity of such innovations unleashed on an unsuspecting public?

Is the perfection of life the knowledge of English or Shakespeare, or perhaps.... is it love?